Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy

9Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

The incubation period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rarely >14 days. We report a patient with hypogammaglobulinemia who developed coronavirus disease 2019 (COVID-19) with a confirmed incubation period of at least 21 days. These findings raise concern for a prolonged presymptomatic transmission phase, necessitating a longer quarantine duration in this patient population.

Cite

CITATION STYLE

APA

Koff, A. G., Laurent-Rolle, M., Hsu, J. C. C., & Malinis, M. (2021). Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy. Infection Control and Hospital Epidemiology, 42(10), 1286–1288. https://doi.org/10.1017/ice.2020.1239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free